Close Menu

This article has been updated to include additional information from the complaint against Myriad Genetics filed in the US District Court for the District of South Carolina.

NEW YORK – Myriad Genetics has entered into a $9.1 million settlement agreement to resolve allegations that it improperly billed Medicare for its hereditary cancer tests, after the US Department of Justice declined to intervene in the matter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.